-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: September 2012
#BIF2012 Company Snapshot: ContraFect Corporation
The BIO Investor Forum is fast approaching! Below you’ll find our first Company Snapshot of one of the event’s presenting companies, ContraFect Corporation. Continue reading to learn more about ContraFect’s product, their strategies, and what you can expect from their company in the coming months. Company Snapshot What is your company’s lead product or technology? ContraFect is a private company developing biotherapeutics for resistant, life threatening infections. Our lead compound, CF-301, is a bacteriophage lysin, Read More >
BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable
During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >
Colorado Biotech’s Big Day
Last week, the Colorado BioScience Association (CBSA) hosted its annual BioWest Conference – a one day event attended by more than 500 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. Colorado Public Radio’s Ryan Warner interviewed CBSA’s April Giles about the conference and several innovative biotech companies in the state. Give it a listen.
New Report Shows Strength of Massachusetts’ Biotech Industry
If you read this blog, there’s a good chance you already know that Massachusetts is one of the biggest biotech hubs in the world. The Commonwealth’s successes in biotech economic development can be attributed to a number of things. Perhaps foremost, its world-class universities, such as MIT and Harvard, continue to churn out the innovation that keeps venture groups interested. Meanwhile, established biotechs and Big Pharma continue to focus more and more R&D work in Read More >
The Importance of Encouraging Adult Vaccination This Fall
As National Immunization Awareness Month ends and flu season approaches, many adults around the country are making plans to get their annual influenza vaccine. In recent years, awareness of the need for influenza vaccination among adults has increased, however, immunization rates among US adults to prevent other vaccine-preventable diseases (VPDs) is still well below current public health goals. While getting an influenza vaccine is a great first step, we still have a long way to Read More >
